cas 2215028-64-9|| where to buy 6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

Nom du produit:6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyrazine

: CAS：2215028-64-9; Formule moléculaire：C10H10ClIN4O; Pureté：95%+

Unité d'emballage	Stock disponible	Prix($)
CM479274-1g	in stock	ǆȋƅ
CM479274-5g	in stock	ǺşŸƩ
CM479274-10g	in stock	şƩǠȋ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Notes supplémentaires

Verification code*

refresh

: N° CAS:2215028-64-9; Formule moléculaire:C10H10ClIN4O; Point de fusion:-; Code SMILES:ClC1=CN=C2C(I)=NN(C3CCCCO3)C2=N1; Densité:

: Numéro de catalogue:CM479274; Poids moléculaire:364.57; Point d'ébullition:; N° Mdl:MFCD32220431; Stockage:

: Pyrazolopyrazines; The pyrazolopyrazine ring system is a very interesting class of heterocyclic compounds considered as important scaffolds for many effective bioactive agents with low toxicity, antioxidant, anticonvulsant, antiparasitic, anti-inflammatory, antiviral, antibacterial, anti- Fungal and analgesic activity.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.